NCT05584267

Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy

Multi-omics Evaluation System and Preferred Mode of Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy

• Status: Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 140 (estimated)
• Sponsor: Hunan Province Tumor Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a prospective multicenter clinical study. This study aims to construct an auxiliary decision-making system for lung cancer immunotherapy combined with radiotherapy by fusing three modes of imagomics, clinicopathological features, and molecular pathological features.

Conditions

• Non Small Cell Lung Cancer

Interventions

Type	Name	Description
RADIATION	radiotherapy	Different cohorts received different doses of radiotherapy
DRUG	Chemotherapy + immunotherapy	Chemotherapy + immunotherapy

Timeline

• Start date: 2022-12-25
• Primary completion: 2025-11-01
• Completion: 2026-12-31
• First posted: 2022-10-18
• Last updated: 2024-05-30

Locations

1 site across 1 country: China